Dilemmas in diagnosing Alzheimer's disease: The peril and promise of self-fulfilling prophecies

To date, there are limited empirical data to inform various approaches to communication with patients receiving information on Alzheimer's disease (AD) risk or diagnosis during the pre-symptomatic or minimally symptomatic stages. This article explores the ethical implications of psychological responses known as self-fulfilling prophecies that may impact cognitive decline among individuals diagnosed with or at risk for AD. We describe questions these potential effects raise about the ways clinicians communicate with patients, as well as how caregivers may interact with patients. Recent advancements in biomarkers and treatment for AD underscore the urgency of understanding these phenomena and developing appropriate responses.

Authors

Institutions

Publication Details

Journal
Journal of Alzheimer s Disease
Published
2025-04-21
DOI
https://doi.org/10.1177/13872877251331236
Citations
1
Primary Topic
Mental Health and Psychiatry
Type
article
Field-Weighted Citation Impact
17.27
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dilemmas in diagnosing Alzheimer's disease: The peril and promise of self-fulfilling prophecies

Janet Malek, Ariel Levchenko, Jill O. Robinson, Chi‐Ying Lin et al.
1 citations
Journal of Alzheimer s Disease
Mental Health and Psychiatry
17.27
article

Dilemmas in diagnosing Alzheimer's disease: The peril and promise of self-fulfilling prophecies

Janet Malek, Ariel Levchenko, Jill O. Robinson, Chi‐Ying Lin, Amy L. McGuire, Jennifer Blumenthal‐Barby, Jamie Fong, Joshua M. Shulman, George R. Jackson
article en
1 citations

Abstract

To date, there are limited empirical data to inform various approaches to communication with patients receiving information on Alzheimer's disease (AD) risk or diagnosis during the pre-symptomatic or minimally symptomatic stages. This article explores the ethical implications of psychological responses known as self-fulfilling prophecies that may impact cognitive decline among individuals diagnosed with or at risk for AD. We describe questions these potential effects raise about the ways clinicians communicate with patients, as well as how caregivers may interact with patients. Recent advancements in biomarkers and treatment for AD underscore the urgency of understanding these phenomena and developing appropriate responses.

Journal of Alzheimer s DiseaseVol. 105(3)
Michael E. DeBakey VA Medical Center (US), Baylor College of Medicine (US), Neurological Research Institute (US), Texas Children's Hospital (US)
Openalex Percentile: Top 3%
Mental Health and Psychiatry
17.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Dilemmas in diagnosing Alzheimer's disease: The peril and promise of self-fulfilling prophecies — Janet Malek, Ariel Levchenko, et al. · Journal of Alzheimer s Disease (2025) | TGRS Research Map | TGRS